Abstract
The Plasmodium food vacuole is a sophisticated organelle optimized for hemoglobin metabolism. It is the site of acidification, hemoglobin proteolysis, peptide transport, heme polymerization, detoxification of oxygen radicals, and quinoline action. A number of proteins that function in the food vacuole are known. Among them are aspartic, cysteine, and metalloproteases, an ATP-binding cassette (ABC) transporter, an ATPase, a heme polymerase, and several oxidant defense enzymes. In this chapter, we review the molecular details of food vacuole function and highlight potential targets for antimalarial drug development.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
References
Ting IP, Sherman IW. Carbon dioxide fixation in malaria—I. Kinetic studies in Plasmodium lophurae. Comp Biochem Physiol 1966; 19: 855–869.
Sherman IW Amino acid metabolism and protein synthesis in malarial parasites. Bull WHO 1977; 55: 265–276.
Stryer L Biochemistry. New York: WH Freeman;1988:143–176.
Morrison DB, Jeskey HA. Alterations in some constituents of the monkey erythrocyte infected with Plasmodium knowlesi as related to pigment formation. J Natl Malar Soc 1948; 7: 259–264.
Ball EG, McKee RW, Anfinsen CB, Cruz WO, Geiman Q M. Studies on malarial parasites: IX. Chemical and metabolic changes during growth and multiplication in vivo and in vitro. J Biol Chem 1948; 175: 547–571.
Loria P, Miller S, Foley M, Tilley L. Inhibition of the peroxidative degradation of haem as the basis of action of chloroquine and other quinoline antimalarials. Biochem J 1999; 339: 363–370.
McCormick GJ. Amino acid transport and incorporation in red blood cells of normal and Plasmodium knowlesi-infected Rhesus monkeys. Exp Parasitol 1970; 27: 143–149.
Sherman IW, Tanigoshi L. Incorporation of 14C-amino acids by malaria (Plasmodium lophurae). Int J Biochem 1970; 1: 635–637.
Divo AD, Geary TG, Davis NL, Jensen JB. Nutritional requirements of Plasmodium falciparum in culture. I. Exogenously supplied dialyzable components necessary for continuous growth. J Protozool 1985; 32: 59–64.
Pollet H, Conrad ME. Malaria: extracellular amino acid requirements for in vitro growth of erythrocytic forms of Plasmodium knowlesi. Proc Soc Exp Biol Med 1968; 127: 251–253.
Francis SE, Gluzman IY. Oksman A, Knickerbocker A, Mueller R, Bryant ML, et al. Molecular characterization and inhibition of a Plasmodium falciparum aspartic hemoglobinase. EMBO J 1994; 13: 306–317.
Bailly E, Jambou R, Savel J, Jaureguiberry G. Plasmodium falciparum: differential sensitivity in vitro to E-64 (cysteine protease inhibitor) and pepstatin A (aspartyl protease inhibitor). J Protozool 1992; 39: 593–599.
Rosenthal PJ, Olson JE, Lee GK, Palmer JT, Klaus JL, Rasnick D. Antimalarial effects of vinyl sulfone cysteine proteinase inhibitors. Antimicrob Agents Chemother 1996; 40: 1600–1603.
Rosenthal PJ, Wollish WS, Palmer JT, Rasnick D. Antimalarial effects of peptide inhibitors of a Plasmodium falciparum cysteine proteinase. J Clin Invest 1991; 88: 1467–1472.
Rosenthal PJ. Plasmodium falciparum: effects of proteinase inhibitors on globin hydrolysis by cultured malaria parasites. Exp Parasitol 1995;80:272–281.
Rosenthal PJ, McKerrow JH, Rasnick D, Leech JH. Plasmodium falciparum: inhibitors of lysosomal cysteine proteinases inhibit a trophozoite proteinase and block parasite development. Mol Biochem Parasitol 1989; 35: 177–184.
Pasvol G, Weatherall DJ, Wilson RJM. Effects of foetal haemoglobin on susceptibility of red cells to Plasmodium falciparum. Nature 1977; 270: 171–173.
Wilson, R.J.M., Pasvol G, Weatherall DJ. Invasion and growth of Plasmodium falciparum in different types of human erythrocyte. Bull WHO 1977; 55: 179–186.
Shear HL, Grinberg L, Gilman J, Fabry ME, Stamatoyannopoulos G, Goldberg DE, et al. Transgenic mice expressing human fetal globin are protected from malaria by a novel mechanism. Blood 1998; 92: 2520–2526.
Geary TG, Delaney EJ, Klotz IM, Jensen JB. Inhibition of the growth of Plasmodium falciparum in vitro by covalent modification of hemoglobin. Mol Biochem Parasitol 1983; 9: 59–72.
Rangachari K, Dluzewski AR, Wilson RI. M., Gratzer WB. Cytoplasmic factor required for entry of malaria parasites into RBC’s. Blood 1987; 70: 77–82.
Zarchin S, Krugliak M, Ginsburg H. Digestion of the host erythrocyte by malaria parasites is the primary target for quinoline-containing antimalarials. Biochem Pharmacol 1986; 35: 2435–2442.
Ginsburg H. Some reflections concerning host erythrocyte-malarial parasite interrelationships. Blood Cells 1990; 16: 225–235.
Desai SA, Krogstad DJ, McCleskey EW. A nutrient-permeable channel on the intra-erythrocytic malaria parasite. Nature 1993; 362: 643–646.
Langreth SG, Jensen JB, Reese RT, Trager W. Fine structure in human malaria in vitro. J Protozool 1978; 25: 443–452.
Olliaro PL, Goldberg DE. The Plasmodium digestive vacuole: Metabolic headquarters and choice drug target. Parasitol Today 1995; 11: 294–297.
Slomianny C. Three-dimensional reconstruction of the feeding process of the malaria parasite. Blood Cells 1990; 16: 369–378.
Goldberg DE, Slater AFG, Cerami A, Henderson GB. Hemoglobin degradation in the malaria parasite Plasmodium falciparum: an ordered process in a unique organelle. Proc Natl Acad Sci USA 1990; 87: 2931–2935.
Aikawa M, Hepler PK, Huff CG, Sprinz H. The feeding mechanism of avian malarial parasites. J Cell Biol 1966; 28: 355–373.
Goldberg DE. Hemoglobin degradation in Plasmodium-infected red blood cells. Semin Cell Biol 1993; 4: 355–361.
Aikawa M, Thompson PE. Localization of acid phosphatase activity in Plasmodium berghei and P. gallinaceum: an electron microscopic observation. J Parasitol 1971; 57: 603–610.
Macomber P, Sprinz H. Morphological effects of chloroquine on Plasmodium berghei in mice. Nature 1967; 214: 937–939.
Aikawa M. High-resolution autoradiography of malarial parasites treated with 3H-chloroquine. Am J Pathol 1972; 67: 277–284.
Yayon A, Timberg R, Friedman S, Ginsburg H. Effects of chloroquine on the feeding mechanism of the intraerythrocytic human malarial parasite Plasmodium falciparum. J Protozool 1984; 31: 367–372.
Krugliak M, Waldman Z, Ginsburg H. Gentamicin and amikacin repress the growth of Plasmodium falciparum in culture, probably by inhibiting a parasite acid phospholipase. Life Sci 1987; 40: 1253–1257.
Slomianny C, Prensier G. A cytochemical ultrastructural study of the lysosomal system of different species of malaria parasites. J Protozool 1990; 37: 465–470.
Rudzinska M, Trager W, Bray RS. Pinocytotic uptake and digestion of hemoglobin in malaria parasites. J Protozool 1965; 12: 563–576.
Krogstad DJ, Schlesinger PH, Gluzman IY. Antimalarials increase vesicle pH in Plasmodium falciparum. J Cell Biol 1985; 101: 2302–2309.
Yayon A, Cabantchik ZI, Ginsburg H. Identification of the acidic compartment of Plasmodium falciparum-infected human erythrocytes as the target of the antimalarial drug chloroquine. EMBO J 1984; 3: 2695–2700.
Gyang FN, Poole B, Trager W. Peptidases from Plasmodium falciparum cultured in vitro. Mol Biochem Parasitol 1982; 5: 263–273.
Vander Jagt DL, Hunsaker LA, Campos NM. Comparison of proteases from chloroquinesensitive and chloroquine-resistant strains of Plasmodium falciparum. Biochem Pharmacol 1987; 36: 3285–3291.
Bailly E, Savel J, Mahouy G, Jaureguiberry G. Plasmodium falciparum: isolation and characterization of a 55-kDa protease with a cathepsin D-like activity from P. falciparum. Exp Parasitol 1991; 72: 278–284.
Vander Jagt DL, Hunsaker LA, Campos NM. Characterization of a hemoglobin-degrading, low molecular weight protease from Plasmodium falciparum. Mol Biochem Parasitol, 1986; 18: 389–400.
Levy MR, Siddiqui WA, Chou SC. Acid protease activity in Plasmodium falciparum and P. knowlesi and ghosts of their respective host red cells. Nature 1974; 247: 546–549.
Sherman IW, Tanigoshi L. Purification of Plasmodium lophurae cathepsin D and its effects on erythrocyte membrane proteins. Mol Biochem Parasitol 1983; 8: 207–226.
Levy MR, Chou SC. Activity and some properties of an acid proteinase from normal and Plasmodium berghei-infected red cells. J Parasitol 1973; 59: 1064–1070.
Aissi E, Charet P, Bouquelet S, Biguet J. Endoprotease in Plasmodium yoelii nigeriensis. Comp Biochem Physiol 1983; 74B: 559–566.
Hempelmann E, Wilson RJM. Endopeptidases from Plasmodium knowlesi. Parasitology 1980; 80: 323–330.
Sato K, Fukabori Y, Suzuki M. Plasmodium berghei: a study of globinolytic enzyme in erythrocytic parasite. Zbl Bakt Hyg 1987; 264: 487–495.
Vander Jagt DL, Hunsaker LA, Campos NM, Scaletti JV. Localization and characterization of hemoglobin-degrading aspartic proteinases from the malarial parasite Plasmodium falciparum. Biochim Biophys Acta 1992; 1122: 256–264.
Goldberg DE, Slater AFG, Beavis R, Chait B, Cerami A, Henderson GB. Hemoglobin degradation in the human malaria pathogen Plasmodium falciparum: a catabolic pathway initiated by a specific aspartic protease. J Exp Med 1991; 173: 961–969.
Gluzman IY, Francis SE, Oksman A, Smith CE, Duffin KL, Goldberg DE. Order and specificity of the Plasmodium falciparum hemoglobin degradation pathway. J Clin Invest 1994; 93: 1602–1608.
Francis SE, Gluzman IY, Oksman A, Banerjee D, Goldberg DE. Characterization of native falcipain, an enzyme involved in Plasmodium falciparum hemoglobin degradation. Mol Biochem Parasitol 1996; 83: 189–200.
Dame TB, Reddy GR, Yowell CA, Dunn BM, Kay J, Berry C. Sequence, expression, and modeled structure of an aspartic proteinase from the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 1994; 64: 177–190.
Manning JM. Remote contributions to subunit interactions: lessons from adult and fetal hemoglobins. TIBS 1999; 24: 211–212.
Dianni Carroll C, Patel H, Johnson TO, Guo T, Orlowski M, He Z, et al. Identification of potent inhibitors of Plasmodium falciparum plasmepsin II from an encoded statine combinatorial library. Bioorg Med Chem. Lett 1998; 8: 2315–2320.
Westling J, Yowell CA, Majer P, Erickson JW, Dame JB, Dunn BM. Plasmodium falciparum, P. vivax, P. malariae: a comparison of the active site properties of plasmepsins cloned and expressed from three different species of the malaria parasite. Exp Parasitol 1997; 87: 185–193.
Berry C, Dame JB, Dunn BM, Kay J. Aspartic proteinases from the human malaria parasite Plasmodium falciparum. In: Takahashi K (ed). Aspartic Proteinases: Structure, Function, Biology, and Biomedical Implications, New York: Plenum 1995, pp. 511–518.
Luker KE, Francis SE, Gluzman IY, Goldberg DE. Kinetic analysis of plasmepsins I and II, aspartic proteases of the Plasmodium falciparum digestive vacuole. Mol Biochem Parasitol 1996; 79: 71–78.
Francis SE, Banerjee R, Goldberg DE. Biosynthesis and maturation of the malarial aspartic hemoglobinases plasmepsins I and II. J Biol Chem 1997;272:14, 961–14, 968.
Moon RP, Tyas L, Certa U, Rupp K, Bur D, Jacquet C, et al. Expression and characterization of plasmepsin I from Plasmodium falciparum. Eur J Biochem 1997; 244: 552–560.
Shinagawa T, Do YS, Baxter JD, Carilli C, Schilling J, Hsueh WA. Identification of an enzyme in human kidney that correctly processes prorenin. Proc Natl Acad Sci USA 1990; 87: 1927–1931.
Kim W, Hatsuzawa K, Ishizuka Y, Hashiba K, Murakami K, Nakayama K. A processing enzyme for prorenin in mouse submandibular gland. J Biol Chem 1990; 265: 5930–5933.
Hill J, Tyas L, Phylip LH, Kay J, Dunn BM, Berry C. High level expression and characterisation of plasmepsin II, an aspartic proteinase from Plasmodium falciparum. FEBS Lett 1994; 352: 155–158.
Tyas L, Gluzman IY, Moon RP, Rupp K, Westling J, Ridley RG, et al. Naturally-occurring and recombinant forms of the aspartic proteinases plasmepsins I and II from the malaria parasite Plasmodium falciparum. FEBS Lett 1999; 454: 210–214.
Silva AM, Lee AY, Gulnik SV, Majer, P. et al. Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum. Proc Natl Acad Sci USA 1996;93:10, 034–10, 039.
Hague TS, Skillman G, Lee CE, Habashita H, Gluzman IY, Ewing TJ. et al. Potent low-molecular weight non-peptide inhibitors of malarial aspartyl protease plasmepsin II. J Med Chem 1999; 42: 1428–1440.
Bernstein NK, Cherney MM, Loetscher H, Ridley RG, James MNG. Crystal structure of the novel aspartic proteinase zymogen proplasmepsin II from Plasmodium falciparum. Nature Struct Biol 1999; 6: 32–37.
Deguercy A, Hommel M, Schrevel J. Purification and characterization of 37-kilodalton proteases from Plasmodium falciparum and Plasmodium berghei which cleave erythrocyte cytoskeletal components. Mol Biochem Parasitol 1990; 38: 233–244.
Le Bonniec S, Deregnaucourt C, Redeker V, Banerjee R, Grellier P, Goldberg DE, et al. Plasmepsin II, an acidic hemoglobinase from the Plasmodium falciparum food vacuole is active at neutral pH on the host erythrocyte membrane skeleton. J Biol Chem 1999;274: 14, 218–14, 223.
Rosenthal PJ, McKerrow JH, Aikawa M, Nagasawa H, Leech JH. A malarial cysteine proteinase is necessary for hemoglobin degradation by Plasmodium falciparum. J Clin Invest 1988; 82: 1560–1566.
Gamboa de Dominguez ND, Rosenthal PJ. Cysteine proteinase inhibitors block early steps in hemoglobin degradation by cultured malaria parasites. Blood 1996; 87: 4448–4454.
Rosenthal PJ, Nelson RG. Isolation and characterization of a cysteine proteinase gene of Plasmodium falciparum. Mol Biochem Parasitol 1992; 51: 143–152.
Salas F, Fichmann J, Lee GK, Scott MD, Rosenthal PJ. Functional expression of falcipain, a Plasmodium falciparum cysteine proteinase, supports its role as a malarial hemoglobinase. Infect Immun 1995; 63: 2120–2125.
Rosenthal Pi. A Plasmodium vinckei cysteine proteinase shares unique features with its Plasmodium falciparum analogue. Biochim Biophys Acta 1993; 1173: 91–93.
Rosenthal PJ. Conservation of key amino acids among the cysteine proteinases of multiple malarial species. Mol Biochem Parasitol 1996; 75: 255–260.
Olson JE, Lee GK, Semenov A, Rosenthal PJ. Antimalarial effects in mice of orally administered peptidyl cysteine protease inhibitors. Bioorg Med Chem 1999; 7: 633–638.
Rosenthal PJ, Lee GK, Smith RE. Inhibition of a Plasmodium vinckei cysteine proteinase cures murine malaria. J Clin Invest 1993; 91: 1052–1056.
Eggleson KK, Duffin KL, Goldberg DE. Identification and characterization of falcilysin, a metallopeptidase involved in hemoglobin catabolism within the malaria parasite Plasmodium falciparum. J Biol Chem 1999;274:32, 411–32, 417.
Bray PG, Janneh O, Raynes KJ, Mungthin M, Ginsburg H, Ward SA. Cellular uptake of chloroquine is dependent on binding to ferriprotoporphyrin IX and is independent of NHE activity in Plasmodium falciparum. J Cell Biol 1999; 145: 363–376.
Kolakovich KA, Gluzman IY, Duffin KL, Goldberg DE. Generation of hemoglobin peptides in the acidic digestive vacuole of Plasmodium falciparum implicates peptide transport in amino acid production. Mol Biochem Parasitol 1997; 87: 123–135.
Florent I, Derhy Z, Allary M, Monsigny M, Mayer R, Schrevel J. A Plasmodium falciparum aminopeptidase gene belonging to the M1 family of zinc-metallopeptidases is expressed in erythrocytic stages. Mol Biochem Parasitol 1998; 97: 149–160.
Vander Jagt DL, Baack BR, Hunsaker LA. Purification and characterization of an aminopeptidase from Plasmodium falciparum. Mol Biochem Parasitol 1984; 10: 45–54.
Curley GP, O’Donovan S, McNally J, Mullally M, O’Hara H, Troy A, et al. Aminopeptidases from Plasmodium falciparum, Plasmodium chabaudi chabaudi, and Plasmodium berghei. J Euk Microbiol 1994; 41: 119–123.
Nankya-Kitaka MF, Curley GP, Gavigan CS, Bell A, Dalton JP. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin. Parasitol Res 1998; 84: 552–558.
Berry C, Humphreys Mi., Matharu P, Granger R, Horrocks P, Moon RP, et al. A distinct member of the aspartic proteinase gene family from the human malaria parasite Plasmodium falciparum. FEBS Lett 1999; 447: 149–154.
Xie S, Low BG, Nagel RJ, Kramer KK, Anthony RV, Zoli AP, et al. Identification of the major pregnancy-specific antigens of cattle and sheep as inactive members of the aspartic proteinase family. Proc Natl Acad Sci USA 1991;88:10, 247–10, 251.
Xie S, Green J, Beckers J, Roberts RM. The gene encoding bovine pregnancy-associated glycoprotein-1, an inactive member of the aspartic proteinase family. Gene 1995; 159: 193–197.
Guruprasad K, Blundell TL, Xie S, Green J, Szafranska B, Nagel RJ, et al. Comparative modelling and analysis of amino acid substitutions suggests that the family of pregnancy-associated glycoproteins includes both active and inactive aspartic proteinases. Protein Engin 1996; 9: 849–856.
Xie S., G., J., Bixby JB, Szafranska B, DeMartini JC, Hecht S, Roberts RM. The diversity and evolutionary relationships of the pregnancy-associated glycoproteins, an aspartic proteinase subfamily consisting of many trophoblast-expressed genes. Proc Natl Acad Sci USA 1997;94:12, 809–12, 816.
Elmendorf HG, Haldar K. Identification and localization of ERD2 in the malaria parasite Plasmodium falciparum: separation from sites of sphingomyelin synthesis and implication for organization of the Golgi. EMBO J 1993; 12: 4763–4773.
Van Wye J, Ghori N, Webster P, Mitschler RR, Elmendorf HG, Haldar K. Identification and localization of rab6, separation of rab6 from ERD2 and implications for an unstacked Golgi, in Plasmodium falciparum. Mol Biochem Parasitol 1996; 83: 107–120.
Mattei D, Ward GE, Langsley G, Lingelbach K. Novel secretory pathways in Plasmodium Parasitol Today 1999; 15: 235–237.
Crary JL, Haldar K. Brefeldin A inhibits protein secretion and parasite maturation in the ring stage of Plasmodium falciparum. Mol Biochem Parasitol 1992; 53: 185–192.
Moura IC, Pudles J. A Plasmodium chabaudi chabaudi high molecular mass glycoprotein translocated to the host cell membrane by a non-classical secretory pathway. Eur J Cell Biol 1999; 78: 186–193.
Elmendorf HG, Bangs JD, Haldar K. Synthesis and secretion of proteins by released malarial parasites. Mol Biochem Parasitol 1992; 52: 215–230.
Kimura EA, Couto AS, Peres VJ, Casal OL, Katzin AM. N-Linked glycoproteins are related to schizogony of the intraerythrocytic stage in Plasmodium falciparum. J Biol Chem 1996;271:14, 452–14, 461.
Dieckmann-Schuppert A, Bause E, Schwarz RT. Studies on 0-glycans of Plasmodium falciparum-infected human erythrocytes: evidence for O-G1cNAc and transferase in malaria parasites. Eur J Biochem 1993; 216: 779–788.
Dieckmann-Schuppert A, Bender S, Odenthal-Schnittler M, Bause E, Schwarz RT. Apparent lack of N-glycosylation in the asexual intraerythrocytic stage of Plasmodium falciparum. Eur J Biochem 1992; 205: 815–825.
Gowda DC, Gupta P, Davidson EA. Glycosylphosphatidylinositol anchors represent the major carbohydrate modification in proteins of intraerythrocytic stage Plasmodium falciparum. J Biol Chem 1997; 272: 6428–6439.
Klionsky DJ, Banta LM, Emr SD. Intracellular sorting and processing of a yeast vacuolar hydrolase: proteinase A propeptide contains vacuolar targeting information. Mol Cell Biol 1988; 8: 2105–2116.
Valls LA, Hunter CP, Rothman JH, Stevens TH. Protein sorting in yeast: the localization determinant of yeast vacuolar carboxypeptidase Y resides in the propeptide. Cell, 1987; 48: 887–897.
Oda MN, Scott SV, Hefner-Gravink A, Caffarelli AD, Klionsky DJ. Identification of a cytoplasm to vacuole targeting determinant in aminopeptidase I. J Cell Biol 1996; 132: 999–1010.
Johnson LM, Bankaitis VA, Emr SD, Distinct sorting determinants direct intracellular sorting and modification of a yeast vacuolar protease. Cell 1987; 48: 875–885.
Karcz SR, Herrmann VR, Trottein F, Cowman AF. Cloning and characterization of the vacuolar ATPase B subunit from Plasmodium falciparum. Mol Biochem Parasitol 1994; 65: 123–133.
Cowman AF, Karcz S, Galatis D, Culvenor JG. A P-glycoprotein homologue of Plasmodium falciparum is localized on the digestive vacuole. J Cell Biol 1991; 114: 1033–1042.
Sullivan DJ, Gluzman IY, Goldberg DE. Plasmodium hemozoin formation mediated by histidine-rich proteins. Science 1996; 271: 219–222.
Choi I, Mego JL. Intravacuolar proteolysis in Plasmodium falciparum digestive vacuoles is similar to intralysosomal proteolysis in mammalian cells. Biochim Biophys Acta 1987; 926: 170–176.
Choi I, Mego JL. Purification of Plasmodium falciparum digestive vacuoles and partial characterization of the vacuolar membrane ATPase. Mol Biochem Parasitol 1988; 31: 71–78.
Saliba KJ, Folb PI, Smith PJ. Role for the Plasmodium falciparum digestive vacuole in chloroquine resistance. Biochem Pharm 1998; 56: 313–320.
Karcz SR, Herrmann VR, Cowman AF. Cloning and characterization of a vacuolar ATPase A subunit homologue from Plasmodium falciparum. Mol Biochem Parasitol 1993; 58: 333–344.
Rubio JP, Cowman AF. The ATP-binding cassette (ABC) gene family of Plasmodium falciparum. Parasitol Today 1996; 12: 135–140.
Wilson CM, Serrano AE, Wasley A, Bogenschutz MP, Shankar AH, Wirth DF. Amplification of a gene related to mammalian mdr genes in drug-resistant Plasmodium falciparum. Science 1989; 244: 1184–1186.
Karcz SR, Galatis D, Cowman AF. Nucleotide binding properties of a P-glycoprotein homologue from Plasmodium falciparum. Mol Biochem Parasitol 1993; 58: 269–276.
Lim A, Cowman AF. Phosphorylation of a P-glycoprotein homologue in Plasmodium falciparum. Mol Biochem Parasitol 1993; 62: 293–302.
Van Es H, Karcz S, Chu F, Cowman AF, Vidal S, Gros P, et al. Expression of the plasmo-dial pfmdrl gene in mammalian cells is associated with increased susceptibility to chloroquine. Mol Cell Biol 1994; 14: 2419–2428.
Volkman SK, Cowman AF, Wirth DF. Functional complementation of the ste6 gene of Saccharomyces cerevisiae with the pfmdrl gene of Plasmodium falciparum. Proc Natl Acad Sci USA 1995; 92: 8921–8925.
Volkman S, Wirth D. Functional analysis of pfmdrl gene of Plasmodium falciparum. Methods Enzymol 1998; 292: 174–181.
Cowman AF, Karcz S. Drug resistance and the P-glycoprotein homologues of Plasmodium falciparum. Semin Cell Biol 1993; 4: 29–35.
Cowman AF, Galatis D, Thompson JK. Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdrl gene and cross-resistance to halofantrine and quinine. Proc Natl Acad Sci USA 1994; 91: 1143–1147.
Vennerstrom JL, Eaton JW. Oxidants, oxidant drugs, and malaria. J Med Chem 1988; 31: 1269–1277.
Atamna H, Ginsburg H. Origin of reactive oxygen species in erythrocytes infected with Plasmodium falciparum. Mol Biochem Parasitol 1993; 61: 231–242.
Wallace WJ, Hourchens RA, Maxwell JC, Caughey WS. Mechanism of autooxidation for hemoglobins and myoglobins. J Biol Chem 1982; 257: 4966–4977.
Arias AE, Walter RD. Plasmodium falciparum: association with erythrocyte superoxide dismutase. J Protozool 1988; 35: 348–351.
Fairfield AS, Meshnick SR. Malaria parasites adopt host cell superoxide dismutase. Science, 1983; 221: 764–766.
Fairfield AS, Eaton JW, Meshnick SR. Superoxide dismutase and catalase in the murine malaria, Plasmodium berghei: content and subcellular distribution. Arch Biochem Biophys 1986; 250: 526–529.
Williams WJ, Beutler E, Erslev AJ, Lichtman MA. Hematology. New York: McGraw-Hill, 1990, p. 319.
Fairfield AS, Abosch A, Ranz A, Eaton JW, Meshnick SR. Oxidant defense enzymes of Plasmodium falciparum. Mol Biochem Parasitol 1988; 30: 77–82.
Gamain B, Langsley G, Fourmaux MN, Touzel JP, Camus D, Dive D, et al. Molecular characterization of the glutathione peroxidase gene of the human malaria parasite Plasmodium falciparum. Mol Biochem Parasitol 1996; 78: 237–248.
Friedman MJ. Oxidant damage mediates variant red cell resistance to malaria. Nature 1979; 280: 245–247.
Eckman JR, Eaton JW. Dependence of plasmodial glutathione metabolism on the host cell. Nature 1979; 278: 754–756.
Weatherall DJ. Host genetics and infectious disease. Parasitology, 1996; 112: S23 - S29.
Destro-Bisol G, Giardina B, Sansonetti B, Spedini G. Interaction between oxidized hemoglobin and the cell membrane: a common basis for several falciparum malaria-linked genetic traits. Yearbook Phys Anthropol 1996; 39: 137–159.
Su X, Kirkman LA, Fujioka H, Wellems TE. Complex polymorphisms in a 330-kDa protein are linked to chloroquine-resistant P. falciparum in southeast Asia and Africa. Cell 1997; 91: 593–603.
Sanchez CP, Horrocks P, Lanzer M. Is the putative chloroquine resistance mediator CG2 the Na+/H+ exchanger of Plasmodium falciparum? Cell 1998; 92: 601–602.
Wellems TE, Wootton JC, Fujioka H, Su X, Cooper, R., Baruch D, et al. P. falciparum CG2, linked to chloroquine resistance, does not resemble Na+/H+ exchangers. Cell 1998; 94: 285–286.
Wellems TE, Howard RJ. Homologous genes encode two distinct histidine-rich proteins in a cloned isolate of Plasmodium falciparum. Proc Natl Acad Sci USA 1986; 83: 6065–6069.
Howard RJ, Uni S, Aikawa M, Aley SB, Leech JH, Lew AM, et al. Secretion of a malarial histidine-rich protein (PfHRP II) from Plasmodium falciparum-infected erythrocytes. J Cell Biol 1986; 103: 1269–1277.
Parra ME, Evans CB, Taylor DW. Identification of Plasmodium falciparum histidine-rich protein II in the plasma of humans with malaria. J Clin Microbiol 1991; 29: 1629–1634.
Dorn A, Stoffel R, Matile H, Bubendorf A, Ridley RG. Malarial haemozoin/(3-haematin supports haem polymerization in the absence of protein. Nature 1995; 374: 269–271.
Panton LJ, McPhie P, Maloy WL, Wellems TE, Taylor DW, Howard RJ. Purification and partial characterization of an unusual protein of Plasmodium falciparum: histidine-rich protein II. Mol Biochem Parasitol 1989; 35: 149–160.
Schwarzer E, Turrini F, Ulliers D, Giribaldi G, Ginsburg H, Arese P. Impairment of macrophage functions after ingestion of Plasmodium falciparum-infected erythrocytes or isolated malarial pigment. J Exp Med 1992; 176: 1033–1041.
Banyal HS, Chevli R, Fitch CD. Hemin lyses malaria parasites. Science 1981; 214: 667–669.
Srivastava P, Pandey VC. Herne oxygenase and related indices in chloroquine-resistant and sensitive strains of Plasmodium berghei. Int J Parasitol 1995; 25: 1061–1064.
Slater A, Swiggard WJ, Orton BR, Flitter WD, Goldberg DE, Cerami A, et al. An ironcarboxylate bond links the heure units of malaria pigment. Proc Natl Acad Sci USA 1991; 88: 325–329.
Slater AFG, Cerami A. Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites. Nature 1992; 355: 167–169.
Francis SE, Sullivan DJ, Goldberg DE. Hemoglobin metabolism in the malaria parasite Plasmodium falciparum. Annu. Rev. Microbiol 1997; 51: 97–123.
Oliveira MF, Silva JR, Dansa-Petretski M, de Souza W, Lins U, Braga CM. S., et al. Haem detoxification by an insect. Nature 1999; 400: 517–518.
Homewood CA, Jewsbury JM. Comparison of malarial and schistosome pigment. Trans R Soc Trop Med Hyg 1972; 66: 1–2.
Ginsburg H, Famin O, Zhang J, Krugliak M. Inhibition of glutathione-dependent degradation of heure by chloroquine and amodiaquine as a possible basis for their antimalarial mode of action. Biochem Pharmacol 1998; 56: 1305–1313.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2001 Springer Science+Business Media New York
About this chapter
Cite this chapter
Banerjee, R., Goldberg, D.E. (2001). The Plasmodium Food Vacuole. In: Rosenthal, P.J. (eds) Antimalarial Chemotherapy. Infectious Disease. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-59259-111-4_4
Download citation
DOI: https://doi.org/10.1007/978-1-59259-111-4_4
Publisher Name: Humana Press, Totowa, NJ
Print ISBN: 978-1-61737-124-0
Online ISBN: 978-1-59259-111-4
eBook Packages: Springer Book Archive